Topic Statement: Glenmark Pharma, despite a minor correction, remains on a bullish trajectory with strong support levels.
Key Points:
1. A head and shoulders pattern led to a price breakdown and a brief correction.
2. The stock found support at the uptrend line, maintaining its bullish structure.
3. The price is at the 38.2% retracement level, a key support area previously held in July and August 2024.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在
使用條款閱讀更多資訊。